BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31440897)

  • 1. Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression.
    Varghese S; Geller JC; Ohlow MA
    Herzschrittmacherther Elektrophysiol; 2019 Sep; 30(3):306-312. PubMed ID: 31440897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision regret in implantable cardioverter-defibrillator recipients : A cross-sectional analysis on patients that regret their decision after ICD implantation.
    Varghese S; Geller JC; Ohlow MA
    Herzschrittmacherther Elektrophysiol; 2020 Mar; 31(1):77-83. PubMed ID: 32078717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
    Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients.
    Kraaier K; Starrenburg AH; Verheggen RM; van der Palen J; Scholten MF
    Neth Heart J; 2013 Apr; 21(4):191-5. PubMed ID: 23184599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
    Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
    Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
    Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
    J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.
    Undavia M; Goldstein NE; Cohen P; Sinthawanarong K; Singson M; Bhutani D; Munson T; Gomes JA; Fischer A; Mehta D
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1411-8. PubMed ID: 18950298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study.
    Miller JL; Thylén I; Elayi SC; Etaee F; Fleming S; Czarapata MM; Lennie TA; Moser DK
    J Psychosom Res; 2019 May; 120():39-45. PubMed ID: 30929706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.
    Rahmawati A; Chishaki A; Ohkusa T; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H
    J Arrhythm; 2016 Apr; 32(2):102-7. PubMed ID: 27092190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.
    Bedair R; Babu-Narayan SV; Dimopoulos K; Quyam S; Doyle AM; Swan L; Gatzoulis MA; Wong T
    Int J Cardiol; 2015 Feb; 181():218-24. PubMed ID: 25528316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
    Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.